Stock News

Celgene (CELG) Holder Johnson Investment Counsel Trimmed Its Holding by $3.51 Million; Tim Participacoes S A (TSU) Shareholder Permian Investment Partners LP Has Trimmed Holding by $16.54 Million as Shares Declined

TIM Participações S.A. (NYSE:TSU) Logo

Permian Investment Partners Lp decreased its stake in Tim Participacoes S A (TSU) by 28.13% based on its latest 2018Q1 regulatory filing with the SEC. Permian Investment Partners Lp sold 787,417 shares as the company’s stock declined 16.53% with the market. The institutional investor held 2.01 million shares of the telecommunications equipment company at the end of 2018Q1, valued at $43.59M, down from 2.80 million at the end of the previous reported quarter. Permian Investment Partners Lp who had been investing in Tim Participacoes S A for a number of months, seems to be less bullish one the $8.03 billion market cap company. The stock decreased 1.62% or $0.28 during the last trading session, reaching $17.04. About 737,467 shares traded. TIM Participações S.A. (NYSE:TSU) has risen 23.91% since June 21, 2017 and is uptrending. It has outperformed by 11.34% the S&P500. Some Historical TSU News: 17/05/2018 – TIM PARTICIPAÇÕES BRAND USE AGREEMENT WITH TELECOM ITALIA IS VALID UNTIL DECEMBER 2020; 06/03/2018 – Brazil’s TIM Participações outlines growth plans, projects margin growth; 17/05/2018 – TIM PARTICIPAÇÕES WILL PAY TELECOM ITALIA 0.5 PCT OF ITS NET REVENUES FOR BRAND USE – FILING; 06/03/2018 – BRAZIL’S TIM PARTICIPACOES PROJECTS ABOUT 12 BLN REAIS IN CAPEX IN 2018-2020 PERIOD; 06/03/2018 BRAZILIAN WIRELESS CARRIER TIM PARTICIPACOES PROJECTS 5-7 PCT GROWTH IN SERVICE REVENUE IN 2018; 17/05/2018 – TIM PARTICIPACOES SA TIMP3.SA : HSBC RAISES TARGET PRICE TO BRL 12 FROM BRL 8.75; RATING REDUCE; 17/05/2018 – BRAZILIAN CARRIER TIM PARTICIPAÇÕES WILL PAY ROYALTIES TO TELECOM ITALIA FOR BRAND USE – FILING; 16/03/2018 – JOAO COX IS NEW CHAIRMAN OF THE BOARD OF TIM PARTICIPAÇÕES- FILING; 06/03/2018 – BRAZIL’S TIM PARTICIPACOES PROJECTS 96 PCT OF BRAZIL URBAN POPULATION COVERED BY 4G BY 2020; 06/04/2018 – TIM PARTICIPAÇÕES S.A.: Filing of annual report on Form 20-F for the year ended in December 31, 2017

Johnson Investment Counsel Inc decreased its stake in Celgene Corp (CELG) by 42.57% based on its latest 2018Q1 regulatory filing with the SEC. Johnson Investment Counsel Inc sold 39,404 shares as the company’s stock declined 18.51% with the market. The institutional investor held 53,148 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $4.74 million, down from 92,552 at the end of the previous reported quarter. Johnson Investment Counsel Inc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $57.36B market cap company. The stock decreased 0.79% or $0.63 during the last trading session, reaching $79.14. About 3.42 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 32.65% since June 21, 2017 and is downtrending. It has underperformed by 45.22% the S&P500. Some Historical CELG News: 24/05/2018 – CELGENE CORP – REMAINING AUTHORIZATION WILL BE USED IN CONTINUING OPEN-ENDED PROGRAM EFFECTIVE IMMEDIATELY; 09/04/2018 – Merck: Keytruda Monotherapy Meets Primary Endpoint in Phase 3 Study; 09/04/2018 – The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Celgene Corporation (CELG); 28/03/2018 – Bluebird whistles up a co-development/co-commercialization pact with Celgene on bb2121 CAR-T $BLUE $CELG; 10/04/2018 – The University of Texas MD Anderson Cancer Center and Nanobiotix Have an Agreement to Run lmmunotherapeutic Pre-Clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab; 02/04/2018 – CELGENE SAYS SMITH’S PRIMARY DUTIES TO BE ASSUMED BY ALLES; 20/03/2018 – PROTHENA TO RECEIVE $100M UPFRONT, $50M INVESTMENT BY CELGENE; 04/05/2018 – CELGENE SEES FY ADJ EPS $8.45; 09/04/2018 – POLL: Which of the recent large cell/gene therapy deals will work out best for the acquirer? $NVS $AVXS $CELG $GILD; 04/05/2018 – CELGENE CORP – WITH MULTIPLE CATALYSTS FOR GROWTH EXPECTED OVER NEXT 12 TO 18 MONTHS, REAFFIRMING 2020 OUTLOOK

Analysts await TIM Participações S.A. (NYSE:TSU) to report earnings on July, 24. They expect $0.25 earnings per share, up 78.57% or $0.11 from last year’s $0.14 per share. TSU’s profit will be $117.84M for 17.04 P/E if the $0.25 EPS becomes a reality. After $0.15 actual earnings per share reported by TIM Participações S.A. for the previous quarter, Wall Street now forecasts 66.67% EPS growth.

Among 7 analysts covering TIM Participacoes (NYSE:TSU), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. TIM Participacoes had 30 analyst reports since August 5, 2015 according to SRatingsIntel. As per Wednesday, August 5, the company rating was downgraded by JP Morgan. Barclays Capital downgraded TIM Participações S.A. (NYSE:TSU) on Friday, May 11 to “Equal-Weight” rating. The firm earned “Hold” rating on Tuesday, October 3 by RBC Capital Markets. As per Monday, October 17, the company rating was upgraded by Barclays Capital. As per Tuesday, February 13, the company rating was maintained by Barclays Capital. Barclays Capital maintained TIM Participações S.A. (NYSE:TSU) on Thursday, July 27 with “Overweight” rating. As per Friday, May 26, the company rating was upgraded by JP Morgan. The rating was downgraded by Goldman Sachs on Friday, December 18 to “Sell”. The stock of TIM Participações S.A. (NYSE:TSU) earned “Overweight” rating by Morgan Stanley on Monday, January 23. The stock has “Equal-Weight” rating by Barclays Capital on Tuesday, October 6.

Permian Investment Partners Lp, which manages about $823.32 million and $733.68 million US Long portfolio, upped its stake in Sealed Air Corp New (NYSE:SEE) by 219,825 shares to 2.00 million shares, valued at $85.77M in 2018Q1, according to the filing. It also increased its holding in Us Foods Hldg Corp by 1.57M shares in the quarter, for a total of 3.44 million shares, and has risen its stake in Wisdomtree Tr (DXJ).

Investors sentiment decreased to 0.79 in Q1 2018. Its down 0.04, from 0.83 in 2017Q4. It turned negative, as 120 investors sold CELG shares while 470 reduced holdings. 106 funds opened positions while 363 raised stakes. 513.18 million shares or 8.59% less from 561.38 million shares in 2017Q4 were reported. Logan stated it has 97,520 shares or 0.61% of all its holdings. Synovus Finance Corp holds 0.06% or 41,340 shares in its portfolio. Biondo Advsr Ltd Liability Corporation reported 112,276 shares stake. Main Street Research Ltd Liability reported 11,293 shares or 0.18% of all its holdings. Lateef Inv Management L P, California-based fund reported 228,062 shares. Gulf Intll National Bank & Trust (Uk) Ltd has 245,012 shares. Point72 Asset Management LP holds 0.04% or 96,800 shares in its portfolio. South Dakota Invest Council holds 0.44% or 213,534 shares in its portfolio. Wealthtrust reported 0.01% stake. Deutsche National Bank Ag owns 8.59 million shares. Cap Advisors Limited Co invested in 0.01% or 200 shares. Acg Wealth holds 0.34% in Celgene Corporation (NASDAQ:CELG) or 24,887 shares. Teewinot Capital Advisers Llc reported 72,909 shares or 2.3% of all its holdings. Aviance Partners invested 0.52% in Celgene Corporation (NASDAQ:CELG). Johnson Inv Counsel Incorporated has invested 0.12% in Celgene Corporation (NASDAQ:CELG).

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 EPS, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36 billion for 10.58 P/E if the $1.87 EPS becomes a reality. After $1.61 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Since February 8, 2018, it had 2 buys, and 5 sales for $5.91 million activity. 18,500 shares valued at $1.77 million were sold by KAPLAN GILLA on Thursday, February 15. MARIO ERNEST sold $1.26M worth of stock. LOUGHLIN JAMES J had sold 9,250 shares worth $851,093 on Monday, March 12. On Thursday, June 7 CASEY MICHAEL D sold $1.02 million worth of Celgene Corporation (NASDAQ:CELG) or 13,000 shares.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 21 have Buy rating, 1 Sell and 13 Hold. Therefore 60% are positive. Celgene Corporation had 151 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, November 6, the company rating was maintained by Canaccord Genuity. The rating was maintained by BMO Capital Markets with “Outperform” on Friday, November 17. The stock has “Hold” rating by Argus Research on Wednesday, May 23. The rating was downgraded by Cantor Fitzgerald on Friday, October 27 to “Neutral”. The rating was maintained by Cantor Fitzgerald with “Buy” on Friday, July 24. The company was maintained on Wednesday, February 28 by Robert W. Baird. The company was downgraded on Wednesday, December 27 by Bernstein. On Friday, April 29 the stock rating was maintained by Suntrust Robinson with “Buy”. As per Thursday, January 25, the company rating was maintained by SunTrust. The company was maintained on Friday, April 13 by Morgan Stanley.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *